Method for treating fibromyalgia
US8802706B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Aug 7, 2009 |
| Grant date | Aug 12, 2014 |
| Priority date | — |
| Expiry date | Jul 5, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a therapeutic or prophylactic agent for generalized pain syndrome, for which no cause and therapies have been established. A therapeutic or prophylactic agent for generalized pain syndrome containing an LPA1 antagonist or autotaxin-inhibiting substance as an active ingredient. The pharmaceutical is preferably administered to the central nervous system. The generalized pain syndrome is preferably fibromyalgia, chronic fatigue syndrome or hypersensitivity colitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.